Sergio Espinosa-Ortiz

Pamplona, NC, Spain

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications

Complement C5a induces the formation of neutrophil extracellular traps by myeloid-derived suppressor cells to promote metastasis.

Complement C5a induces the formation of neutrophil extracellular traps by myeloid-derived suppressor cells to promote metastasis.

Journal: Cancer letters
Published: October 22, 2021

Design and validation of a tunable inertial microfluidic system for the efficient enrichment of circulating tumor cells in blood.

Design and validation of a tunable inertial microfluidic system for the efficient enrichment of circulating tumor cells in blood.

Journal: Bioengineering & translational medicine
Published: October 06, 2021

Tumor ENPP1 (CD203a)/Haptoglobin Axis Exploits Myeloid-Derived Suppressor Cells to Promote Post-Radiotherapy Local Recurrence in Breast Cancer.

Tumor ENPP1 (CD203a)/Haptoglobin Axis Exploits Myeloid-Derived Suppressor Cells to Promote Post-Radiotherapy Local Recurrence in Breast Cancer.

Journal: Cancer discovery
Published: July 16, 2021

SRC family kinase (SFK) inhibitor dasatinib improves the antitumor activity of anti-PD-1 in NSCLC models by inhibiting Treg cell conversion and proliferation.

SRC family kinase (SFK) inhibitor dasatinib improves the antitumor activity of anti-PD-1 in NSCLC models by inhibiting Treg cell conversion and proliferation.

Journal: Journal for immunotherapy of cancer
Published: January 12, 2021

Id1 and PD-1 Combined Blockade Impairs Tumor Growth and Survival of KRAS-mutant Lung Cancer by Stimulating PD-L1 Expression and Tumor Infiltrating CD8+ T Cells.

Id1 and PD-1 Combined Blockade Impairs Tumor Growth and Survival of KRAS-mutant Lung Cancer by Stimulating PD-L1 Expression and Tumor Infiltrating CD8+ T Cells.

Journal: Cancers
Published: September 22, 2020

FOSL1 promotes cholangiocarcinoma via transcriptional effectors that could be therapeutically targeted.

FOSL1 promotes cholangiocarcinoma via transcriptional effectors that could be therapeutically targeted.

Journal: Journal of hepatology
Published: July 30, 2020

Short-term starvation reduces IGF-1 levels to sensitize lung tumors to PD-1 immune checkpoint blockade.

Short-term starvation reduces IGF-1 levels to sensitize lung tumors to PD-1 immune checkpoint blockade.

Journal: Nature cancer
Published: August 30, 2019

Complementing the Cancer-Immunity Cycle.

Complementing the Cancer-Immunity Cycle.

Journal: Frontiers in immunology
Published: February 01, 2019

Complement in Metastasis: A Comp in the Camp.

Complement in Metastasis: A Comp in the Camp.

Journal: Frontiers in immunology
Published: January 10, 2019

Blockade of the Complement C5a/C5aR1 Axis Impairs Lung Cancer Bone Metastasis by CXCL16-mediated Effects.

Blockade of the Complement C5a/C5aR1 Axis Impairs Lung Cancer Bone Metastasis by CXCL16-mediated Effects.

Journal: American journal of respiratory and critical care medicine
Published: January 13, 2018

Complement anaphylatoxins C3a and C5a: Emerging roles in cancer progression and treatment.

Complement anaphylatoxins C3a and C5a: Emerging roles in cancer progression and treatment.

Journal: Seminars in cell & developmental biology
Published: October 03, 2017

A Combined PD-1/C5a Blockade Synergistically Protects against Lung Cancer Growth and Metastasis.

A Combined PD-1/C5a Blockade Synergistically Protects against Lung Cancer Growth and Metastasis.

Journal: Cancer discovery
Published: October 20, 2016
Showing 1-12 of 12

Last Updated: 09/26/2026